103 related articles for article (PubMed ID: 22688424)
1. HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells.
Wolpert F; Roth P; Lamszus K; Tabatabai G; Weller M; Eisele G
J Neuroimmunol; 2012 Sep; 250(1-2):27-34. PubMed ID: 22688424
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
[TBL] [Abstract][Full Text] [Related]
3. Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy.
Wu A; Wiesner S; Xiao J; Ericson K; Chen W; Hall WA; Low WC; Ohlfest JR
J Neurooncol; 2007 Jun; 83(2):121-31. PubMed ID: 17077937
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis.
Chen LJ; Han ZQ; Zhou H; Zou L; Zou P
Placenta; 2010 Jun; 31(6):519-27. PubMed ID: 20430441
[TBL] [Abstract][Full Text] [Related]
5. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
6. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.
Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN
Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309
[TBL] [Abstract][Full Text] [Related]
7. NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C
J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131
[TBL] [Abstract][Full Text] [Related]
8. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
9. Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells.
Wolpert F; Happold C; Reifenberger G; Florea AM; Deenen R; Roth P; Neidert MC; Lamszus K; Westphal M; Weller M; Eisele G
PLoS One; 2015; 10(10):e0139603. PubMed ID: 26441059
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
11. A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells.
Wolpert F; Tritschler I; Steinle A; Weller M; Eisele G
Neuro Oncol; 2014 Mar; 16(3):382-91. PubMed ID: 24327582
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells.
Zdravkovic M; Aboagye-Mathiesen G; Guimond MJ; Hager H; Ebbesen P; Lala PK
Placenta; 1999; 20(5-6):431-40. PubMed ID: 10419808
[TBL] [Abstract][Full Text] [Related]
13. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
Kaufman DS; Schoon RA; Leibson PJ
J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
[TBL] [Abstract][Full Text] [Related]
14. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.
Lobo PI; Spencer CE
J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
16. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
Zhang C; Tian Z; Hou G
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
[TBL] [Abstract][Full Text] [Related]
17. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
18. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
20. Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells.
Enqvist M; Nilsonne G; Hammarfjord O; Wallin RP; Björkström NK; Björnstedt M; Hjerpe A; Ljunggren HG; Dobra K; Malmberg KJ; Carlsten M
J Immunol; 2011 Oct; 187(7):3546-54. PubMed ID: 21890659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
